Entry DateNovember 2023
Founded in 1999 in Nancy, Banook specializes in in the collection and analysis of clinical trials data derived from electrocardiograms – also called “ECG” – used during clinical trials to assess the cardiac safety of new drugs under development. For over 25 years, Banook has been supporting pharmaceutical laboratories, biotechnology companies, and Contract Research Organizations (CROs) in conducting their clinical trials. As a strategic partner, the Group has a network of renowned Key Opinions Leaders and a distinctive proprietary clinical trial management system (Atrium) that allows secure and automated data centralization.
Historically based in Nancy, Banook has embarked on a strategic international expansion, first establishing a presence in Canada and then Germany through the acquisition of the Munich-based enterprise Nabios Gmbh in 2021. In 2022, the company further expanded by opening an office in Boston. Additionally, the Group has strategically positioned multiple logistic hubs abroad, ensuring the swift provision of medical devices, enabling Banook to efficiently support multi-site clinical trials. Presently, Banook conducts almost two-thirds of its operations outside of France, addressing leading pharmaceutical laboratories. The Group employs ~70 people and is backed by a network of top-tier scientific and medical experts.